In addition, IL-3 plays a role in regulating cell survival and the proliferation of tumor-derived endothelial cells (TEC) and increasing the expression of the AKT signaling pathway and pro-tumorigenic and angiogenic receptors, thereby controlling the tumor microenvironment. The gene discussed is AKT1; the disease is neoplasm.